SlideShare uma empresa Scribd logo
1 de 19
Cancer Dr. G.S. Jogdand, M.D. Ph.D. Professor & Head Community Medicine Department
Definition ,[object Object],[object Object],[object Object],[object Object]
Theories of genesis of cancers ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Origin of cancers ,[object Object],[object Object],[object Object]
Cancers showing Genetic/familial Tendencies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Time trends for cancer ,[object Object],[object Object],[object Object]
Diagnosis of cancer ,[object Object],[object Object],[object Object],[object Object]
Tumor Markers Name Foetal  Ag Normally detected Tumor Carcion Embryonic Antigen yes yes GIT, Lung, Breast Cancer Ag. 125 yes yes Ovary Alpha fetoprotein yes yes Hepato-cellular Ca, germ cell tumors Lactate dehydrogenase No yes Most reflecting tumor burden Prostate specific Antigen No Yes Prostate cancer Human Chorionic Gonadotrophin No Pregnancy Teratoma, chorio-carcinoma
Problem statement: Incidence and mortality of cancer (Global) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Five leading cancers in India ,[object Object],[object Object],[object Object],[object Object],[object Object]
Causes of cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]
Cancer Death Rates, for Women *Age-adjusted to the 2000 US standard population. Source:  US Mortality Public Use Data Tapes 1960-2000, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2003. Lung Colon & rectum Uterus Stomach Breast Ovary Pancreas Rate Per 100,000
Lifetime Probability of Developing Cancer, Men, US, 1998-2000 Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 5.1 Statistical Research and Applications Branch, NCI, 2003. http://srab.cancer.gov/devcan All sites   1 in 2 Cancer
Prevention of cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Secondary prevention ,[object Object],[object Object],[object Object],[object Object]
Cancer education ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Thank you

Mais conteúdo relacionado

Mais procurados (19)

CANCER
CANCERCANCER
CANCER
 
Cell biology and cancer
Cell biology and cancerCell biology and cancer
Cell biology and cancer
 
cancer how when and what
cancer how when and whatcancer how when and what
cancer how when and what
 
Cancer basics
Cancer basicsCancer basics
Cancer basics
 
Cancer PPT (From Mrs. Brenda Lee)
Cancer PPT (From Mrs. Brenda Lee)Cancer PPT (From Mrs. Brenda Lee)
Cancer PPT (From Mrs. Brenda Lee)
 
Cancer slides
Cancer slidesCancer slides
Cancer slides
 
Cancer
CancerCancer
Cancer
 
Cancer Introduction Class
Cancer Introduction ClassCancer Introduction Class
Cancer Introduction Class
 
Cancer
CancerCancer
Cancer
 
Danger of cancer
Danger of cancerDanger of cancer
Danger of cancer
 
Etiology of Cancer
Etiology of CancerEtiology of Cancer
Etiology of Cancer
 
What Is Cancer
What  Is CancerWhat  Is Cancer
What Is Cancer
 
cancer intro and pathogenesis
 cancer intro and pathogenesis cancer intro and pathogenesis
cancer intro and pathogenesis
 
Cancer report
Cancer reportCancer report
Cancer report
 
Introduction to cancer
Introduction to cancerIntroduction to cancer
Introduction to cancer
 
Cancer
CancerCancer
Cancer
 
Cancer And Its Causes
Cancer And Its CausesCancer And Its Causes
Cancer And Its Causes
 
Ca pathogenesispdf
Ca pathogenesispdfCa pathogenesispdf
Ca pathogenesispdf
 
Understanding cancer
Understanding cancerUnderstanding cancer
Understanding cancer
 

Semelhante a Cancer

Semelhante a Cancer (20)

Human Bio Iii Oncology I
Human Bio Iii Oncology IHuman Bio Iii Oncology I
Human Bio Iii Oncology I
 
Cancer
CancerCancer
Cancer
 
Development of cancer
Development of cancerDevelopment of cancer
Development of cancer
 
Cancer
CancerCancer
Cancer
 
neoplasm2. pptx
neoplasm2.                            pptxneoplasm2.                            pptx
neoplasm2. pptx
 
Cancer and tumor markers
Cancer and tumor markersCancer and tumor markers
Cancer and tumor markers
 
Cancer - Dr.Rahul Shrivastava
Cancer - Dr.Rahul ShrivastavaCancer - Dr.Rahul Shrivastava
Cancer - Dr.Rahul Shrivastava
 
Update in oncology
Update in oncologyUpdate in oncology
Update in oncology
 
Pancreatic cancer
Pancreatic cancerPancreatic cancer
Pancreatic cancer
 
1 Introduction To Oncology
1 Introduction To Oncology1 Introduction To Oncology
1 Introduction To Oncology
 
Cancer Powerpoint
Cancer PowerpointCancer Powerpoint
Cancer Powerpoint
 
National cancer control program
National cancer control programNational cancer control program
National cancer control program
 
Oncology
OncologyOncology
Oncology
 
Cancer Report by SVCT Intern Neetu yadav(JBS)
Cancer Report by SVCT Intern Neetu yadav(JBS)Cancer Report by SVCT Intern Neetu yadav(JBS)
Cancer Report by SVCT Intern Neetu yadav(JBS)
 
Cancer
Cancer Cancer
Cancer
 
Malignant disorders
Malignant disorders Malignant disorders
Malignant disorders
 
1. cancer care.pdf medical surgical nursing 1
1. cancer care.pdf medical surgical nursing 11. cancer care.pdf medical surgical nursing 1
1. cancer care.pdf medical surgical nursing 1
 
Cancer Biology bbbbbnnnnbbbbjnbbbbbbbbbh
Cancer Biology bbbbbnnnnbbbbjnbbbbbbbbbhCancer Biology bbbbbnnnnbbbbjnbbbbbbbbbh
Cancer Biology bbbbbnnnnbbbbjnbbbbbbbbbh
 
Etiology of cancer
Etiology of cancerEtiology of cancer
Etiology of cancer
 
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKARANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
ANTI CANCER DRUGS(ANTI NEOPLASTIC AGENTS) BY P.RAVISANKAR
 

Último

REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Pooja Bhuva
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsKarakKing
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Association for Project Management
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxPooja Bhuva
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 

Último (20)

REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 

Cancer

  • 1. Cancer Dr. G.S. Jogdand, M.D. Ph.D. Professor & Head Community Medicine Department
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Tumor Markers Name Foetal Ag Normally detected Tumor Carcion Embryonic Antigen yes yes GIT, Lung, Breast Cancer Ag. 125 yes yes Ovary Alpha fetoprotein yes yes Hepato-cellular Ca, germ cell tumors Lactate dehydrogenase No yes Most reflecting tumor burden Prostate specific Antigen No Yes Prostate cancer Human Chorionic Gonadotrophin No Pregnancy Teratoma, chorio-carcinoma
  • 10.
  • 11.
  • 12.
  • 13.
  • 14. Cancer Death Rates, for Women *Age-adjusted to the 2000 US standard population. Source: US Mortality Public Use Data Tapes 1960-2000, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2003. Lung Colon & rectum Uterus Stomach Breast Ovary Pancreas Rate Per 100,000
  • 15. Lifetime Probability of Developing Cancer, Men, US, 1998-2000 Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 5.1 Statistical Research and Applications Branch, NCI, 2003. http://srab.cancer.gov/devcan All sites 1 in 2 Cancer
  • 16.
  • 17.
  • 18.

Notas do Editor

  1. Currently, the lung cancer death rate in women is about two-and-a-half times what it was 25 years ago, and lung cancer is the most common cause of cancer death. In comparison, breast cancer death rates were virtually unchanged between 1930 and 1990, and have since decreased. The death rates for stomach and uterine cancers have decreased steadily since 1930; colorectal cancer death rates have been decreasing for over 50 years.
  2. The next four slides look at the lifetime probability of developing cancer and relative survival rates of cancer.   Presently, the risk of an American man developing cancer over his lifetime is one in two. The leading cancer sites are prostate, lung, and colon & rectum.